|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02607 SH PHARMA
Nominal 
12.290 +0.160 (+1.319%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 141,592,783 | 1.563% | 139,413,146 | 132,592,157 | 111,707,464 | 105,237,469 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (758,298) | 251.889% | (215,493) | (73,375) | (152,852) | (221,062) | |
| Profit / (Loss) on Disposal | 39,986 | -71.297% | 139,310 | 73,746 | 1,427,180 | 5,925 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 380,664 | 4.117% | 365,613 | (65,419) | 377,555 | 609,988 | |
| Profit / (Loss) before Taxation | 6,820,821 | 41.452% | 4,822,021 | 4,533,793 | 5,757,963 | 5,217,563 | |
| Taxation | (1,826,037) | 49.106% | (1,224,658) | (1,116,791) | (1,193,744) | (1,052,773) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (535,919) | -18.237% | (655,452) | (807,179) | (868,613) | (597,031) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 4,458,865 | 51.564% | 2,941,911 | 2,609,822 | 3,695,607 | 3,567,760 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 749,775 | 6.210% | 705,939 | 773,220 | 648,914 | 578,869 |
| Depreciation & Amortisation | 1,464,970 | 17.293% | 1,248,982 | 1,179,235 | 1,193,683 | 1,176,302 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 120.000 | 51.899% | 79.000 | 71.000 | 113.000 | 126.000 |
| DPS (cts) | 0.000 | -- | 8.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | 10.127% | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 20.250 | -- | 18.898 | 18.189 | 17.674 | 16.789 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 4,458,865 |
| %Change | 51.564% |
| EPS / (LPS) | RMB 1.200 |
| NBV Per Share (¥) | RMB 20.250 |